Status:
UNKNOWN
Fertility After Uterine Artery Embolization
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Gedeon Richter France
Collège National des Gynécologues et Obstétriciens Français
Conditions:
Fertility Disorders
Fertility Issues
Eligibility:
FEMALE
18-45 years
Brief Summary
Uterine leiomyomas (or fibroids) are a common disease (30% of women over 35 years of age) in women of childbearing age and can cause various symptoms such as menometrorrhagia, dysmenorrhoea, pelvic pa...
Eligibility Criteria
Inclusion
- Women ≥ 18 years, ≤ 45 years at the time of their embolisation
- Uterine pathology responsible for disabling symptoms: uterine leiomyomas with no limitations in size, number or location, adenomyosis
- Having had a uterine artery embolisation between 2007 and September 2020
- Minimum delay of one year after embolisation
- Information and no opposition from patients
Exclusion
- Women \< 18 years and \> 45 years at the time of embolisation
- Uterine artery embolisation for delivery haemorrhage
- Patients under court protection, guardianship or curatorship
- Refusal to participate in this research
Key Trial Info
Start Date :
November 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2023
Estimated Enrollment :
833 Patients enrolled
Trial Details
Trial ID
NCT05271981
Start Date
November 23 2022
End Date
November 1 2023
Last Update
April 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Européen Georges Pompidou
Paris, France, 75015